Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis.
Afisi S IsmailaKatrin HaeusslerAlexandrosz CziraJi-Hee YounMia MalmenasNancy A RisebroughJatin AgarwalMaria NassimRaj SharmaChris ComptonClaus F VogelmeierMeilan K HanDavid M G HalpinPublished in: Advances in therapy (2022)
The findings of this NMA suggest favorable efficacy with single-inhaler triple therapy comprising FF/UMEC/VI. Further analysis is required as additional evidence becomes available.